Administration of tamoxifen in the perioperative period to patients with breast carcinoma prolongs axillary fluid drainage

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1245-1248

  Kelessis, Nickos G ^a   Vassilopoulos, Pericles P ^a   Galanopoulou, Agathi V ^a   Nessiotis, Athanassios G ^a   Stravolemos, Couris M ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Axillary drainage; Stroma; Tamoxifen; TGF

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURGERY; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WOUND HEALING;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; AXILLA; BREAST NEOPLASMS; DRAINAGE; FEMALE; HUMANS; LYMPH NODE EXCISION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TAMOXIFEN;

EID: 0034107776     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aitken H, Hunsaker R, James AG: Prevention of seromas following mastectomy and axillary dissection. Surg Gynecol Obstet 158: 327-330, 1984.
2. Artcaga CL, Tandon AK, von Hoff DD, Oshorne CK: Transforming growth factor β: Potential autocrine growth inhibition of estrogen receptor negative human breast cancer cells. Cancer Res 48: 3898-3904, 1988.
3. Benson JR, Baum M, Colletta AA: Role of TGFβ in the anti-estrogen response/resistance of human breast cancer. J Mammary Gland Biol and Neoplasia 1: 381-389, 1996.
4. Bryant M and Baum M: Postoperative seroma following mastectomy and axillary dissection. Br J Surg 74: 1187. 1987.
5. Carrico TJ, Mehthof AI, Cohen IK: Biology of wound healing. Surg Clin North Am 64: 721-733, 1984.
6. Coletta AA, Wakefield LM, Howell FV, van Roozendaal KEP, Daniclpour D, Ebbs SR, Sporn MB, Baum M: Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 62: 405-409, 1990.
7. Colletta AA, Benson JR, Baum M: Alternate mechanisms of action of antioestrogens. Breast Cancer Res Treat 31: 15-19, 1994.
8. Coons MS, Folliguet TA, Rodriguez C, Woloszyn TT, Tuchler RE, Marini CP: Prevention of seroma formation after dissection of musculoskeletal flaps. Am Surg 59: 215-218, 1993.
9. Cromack DT, Sporn MD, Roberts AB, Merino ML, Dart LL, Norton JA: Transforming growth factor-β levels in rat wound chambers. J Surg Res 42: 622-628, 1987.
10. Dawson I, Slam L, Heslinga JM, Kalsbeerk HL: Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy: a randomized prospective clinical trial. Br J Surg 76: 311-312, 1989.
11. Dvonch VM, Murphey RJ, Masuoka J, Grotendorst GR: Changes in growth factor levels in human wound fluid. Surgery 122: 18-23, 1992.
12. Jansen RFM, van Geel AN, de Groot HGW, Rottier AB, Olthuis GAA, van Putten WLJ: Immediate versus delayed shoulder exercises after axillary lymph node dissection. Am J Surg 160: 481-484, 1990.
13. Knight CDJr, Griffen FD, Knight CD: Prevention of scromas in mastectomy woods. The effect of shoulder immobilization. Arch Surg 130: 99-101, 1995.
14. Lindsey W, Masterson T, Spotnitz W, Wilhelm M, Morgan R: Seroma prevention using fibrin glue in a rat mastectomy model. Arch Surg 125: 305-307, 1990.
15. Lotze MT, Quncan MA, Gerber LH, Woltering EA, Rosenberg SA: Early versus delayed shoulder motion following axillary dissection. Ann Surg 193: 288-295, 1980.
16. Nicolas V, Prewett A, Bettica L: Age-related decreases in insulin-like growth factor-1 and transforming growth factor-beta in femoral cortical hone from both men and women: implication for bone loss with aging. J Clin Endocrinol Metab 78: 1011-1016, 1994.
17. Peacock EE and Winkle WV: Wound repair. WB Saunders, Philadelphia, 1976, 2nd ed, pp 1-21.
18. Reid SE, Scanlon EF, Kaufman MW, Murphy MS: Role of cytokines and growth factors in promoting the local recurrence of breast cancer (review). Br J Surg 83: 313-320, 1996.
19. Rew TJ: Wood drainage following radical mastectomy: the effect of restriction of shoulder movement. Br J Surg 66: 302-305, 1979.
20. Say CC and Donegan W: A biostatistical evaluation of complications from mastectomy. Surg Ciynecol Obstet 138: 370-376, 1974.
21. Shultz GS and Grant MB: Neovascular growth factors. Eye (Lond) 5: 178-180, 1991.
22. Sitzmann JV, Dufresne C, Zuidema GD: The use of sclerotherapy for treatment of postoperative wound seromas. Surgery 93: 345-347, 1983.
23. Skipper D, Jeffrey MJ, Cooper AJ, Taylor I, Alexander P: Preferential growth of blood home cancer cells in colonie anastomoses. Br J Cancer 57: 564-568, 1988.
24. Watt-Boolsen S, Nielsen VB, Jensen J, Bak S: Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Danish Medical Bulletin 36: 487-489, 1989.
25. Weiss L, Orr FW, Hohn KV: Interactions of cancer cells with micro-vasculature during metastasis. FASER J 2: 12-21, 1988.
26. Whalen GF and Ingber DE: Inhibition of tumor-cell attachment to extracellular matrix as a method for preventing tumor recurrence in a surgical wound. Ann Surg 210: 758-764, 1989.
27. Zetter BR and Brightman SE: Cell motility and the extracellular matrix. Curr Opin Cell Biol 2: 850-856, 1990.